SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-402854
Filing Date
2014-11-07
Accepted
2014-11-07 13:11:21
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d793512d10q.htm 10-Q 400561
2 EX-31.1 d793512dex311.htm EX-31.1 8248
3 EX-31.2 d793512dex312.htm EX-31.2 8245
4 EX-32.1 d793512dex321.htm EX-32.1 3057
5 EX-32.2 d793512dex322.htm EX-32.2 3055
  Complete submission text file 0001193125-14-402854.txt   3400182

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT clvs-20140930.xml EX-101.INS 366495
7 XBRL TAXONOMY EXTENSION SCHEMA clvs-20140930.xsd EX-101.SCH 40733
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE clvs-20140930_cal.xml EX-101.CAL 49599
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clvs-20140930_def.xml EX-101.DEF 230524
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE clvs-20140930_lab.xml EX-101.LAB 314237
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clvs-20140930_pre.xml EX-101.PRE 272504
Mailing Address 2525 28TH STREET SUITE 100 BOULDER CO 80301
Business Address 2525 28TH STREET SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Filer) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35347 | Film No.: 141203752
SIC: 2834 Pharmaceutical Preparations